Should Biogen Buy Alkermes? Post author:Sam Post published:February 27, 2018 Post category:BioPharma After a huge dry spell in M&A, 2018 is shaping up to be a great year for deal making. Source: BioSpace You Might Also Like SoCal's Capricor to Reduce Workforce and Shift Focus After Discouraging Trial Results May 11, 2017 Ajinomoto Appoints As Vice President Of Compliance April 5, 2017 Monaghan Medical 's Drug-Free Aerobika Device Helps Reduce The Real-World Impact Of Exacerbations In Chronic Obstructive Pulmonary Disease February 23, 2017
Monaghan Medical 's Drug-Free Aerobika Device Helps Reduce The Real-World Impact Of Exacerbations In Chronic Obstructive Pulmonary Disease February 23, 2017
